Title:
SPOKE HAVING ADJUSTABLE LENGTH
Document Type and Number:
WIPO Patent Application WO/2019/088347
Kind Code:
A1
Abstract:
The present invention relates to a spoke having an adjustable length and, more specifically, to a spoke coupled between a hub rotating about a rotating shaft of a wheel and a rim in which a tire is mounted, the spoke comprising: an inner spoke portion having one-end side coupled to the hub and having the shape of a rod having a predetermined length; an outer spoke portion having the shape of a rod having a predetermined length, having one-end side directed toward the hub and the other-end side coupled to the rim; and a joint spoke portion having one-end side coupled to the other-end side of the inner spoke portion and the other-end coupled to one-end side of the outer spoke portion, wherein the length from the one-end of the inner spoke portion to the other-end side of the outer spoke portion can be selectively adjusted, thereby reducing costs necessary for maintenance or management of a wheel and a spoke and improving efficiency and convenience in the maintenance or management of the wheel.
Inventors:
KWEN YOUNG SU (KR)
Application Number:
PCT/KR2017/013957
Publication Date:
May 09, 2019
Filing Date:
November 30, 2017
Export Citation:
Assignee:
KWEN YOUNG SU (KR)
International Classes:
B60B1/00; B60B1/02
Foreign References:
US20120126608A1 | 2012-05-24 | |||
US20110101768A1 | 2011-05-05 | |||
KR101380217B1 | 2014-04-02 | |||
JP2002525235A | 2002-08-13 | |||
KR20070062114A | 2007-06-15 | |||
KR20110093195A | 2011-08-18 | |||
KR101050295B1 | 2011-07-19 |
Attorney, Agent or Firm:
LEE, Joon Sung (KR)
Download PDF:
Previous Patent: HILS-BASED SHIP MANEUVERABILITY MEASUREMENT AND MANAGEMENT SYSTEM
Next Patent: EGFR INHIBITOR-RESISTANT CANCER TREATMENT AGENT
Next Patent: EGFR INHIBITOR-RESISTANT CANCER TREATMENT AGENT